1-20 of 21
Hirohisa Yoshizawa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3206: Programmed death receptor-1/programmed death receptor ligand-1 blockade improves priming of antitumor effector T cells after cytotoxic therapies

Miho Takahashi, Satoshi Watanabe, Ko Sato, Tomohiro Tanaka, Yu Saida, Junko Baba, Aya Ohtsubo, Miyuki Sato, Rie Kondo, Masaaki Okajima, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Toshiaki Kikuchi
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3206.
https://doi.org/10.1158/1538-7445.AM2016-3206
Published: 15 July 2016
View article titled, Abstract 3206: Programmed death receptor-1/programmed death receptor ligand-1 blockade improves priming of antitumor effector T cells after cytotoxic therapies
Journal Articles

Abstract 3153: Critical roles of chemo-resistant effector and regulatory T cells in cancer immunotherapy during hemostatic proliferation

Ko Sato, Satoshi Watanabe, Yu Saida, Tomohiro Tanaka, Junko Baba, Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3153.
https://doi.org/10.1158/1538-7445.AM2015-3153
Published: 01 August 2015
View article titled, Abstract 3153: Critical roles of chemo-resistant effector and regulatory T cells in cancer immunotherapy during hemostatic proliferation
Journal Articles

Abstract 2554: DDX3X-specific effector T cells in small cell lung cancer patients reflect disease stage

Natsue Igarashi, Hiroshi Kagamu, Koichiro Nozaki, Satoshi Shoji, Masaaki Okajima, Satoru Miura, Satoshi Watanabe, Hirohisa Yoshizawa, Ichiei Narita
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2554.
https://doi.org/10.1158/1538-7445.AM2014-2554
Published: 01 October 2014
View article titled, Abstract 2554: DDX3X-specific effector T cells in small cell lung cancer patients reflect disease stage
Journal Articles

Abstract 2818: Dendritic cell vaccination and regulatory T-cell depletion augment antitumor immunity after cytotoxic therapy

Tomohiro Tanaka, Satoshi Watanabe, Ko Sato, Yu Saida, Junko Baba, Koichiro Nozaki, Daisuke Ishikawa, Natsue Igarashi, Satoshi Shoji, Masaaki Okajima, Satoru Miura, Junta Tanaka, Hiroshi Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2818.
https://doi.org/10.1158/1538-7445.AM2014-2818
Published: 01 October 2014
View article titled, Abstract 2818: Dendritic cell vaccination and regulatory T-cell depletion augment antitumor immunity after cytotoxic therapy
Journal Articles

Abstract 3716: DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked plays oncogenic roles to induce cancer stem cell-like properties and resistance to EGFR-TKI.

Koichiro Nozaki, Hiroshi Kagamu, Satoshi Shoji, Natsue Igarashi, Msaaki Okajima, Satoru Miura, Satoshi Watanabe, Hirohisa Yoshizawa, Ichiei Narita
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3716.
https://doi.org/10.1158/1538-7445.AM2013-3716
Published: 15 April 2013
View article titled, Abstract 3716: DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked plays oncogenic roles to induce cancer stem cell-like properties and resistance to EGFR-TKI.
Journal Articles

Abstract 3963: Chemo-resistantregulatory T cells suppress the development of antitumor immunity aftercytotoxic regimens.

Yu Saida, Satoshi Watanabe, Tomohiro Tanaka, Junko Baba, Koh Satoh, Satoshi Shoji, Natsue Igarashi, Koichirou Nozaki, Masaaki Okajima, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3963.
https://doi.org/10.1158/1538-7445.AM2013-3963
Published: 15 April 2013
View article titled, Abstract 3963: Chemo-resistantregulatory T cells suppress the development of antitumor immunity aftercytotoxic regimens.
Journal Articles

Abstract 1550: Successful treatment of advanced tumors with chemo-immunotherapy: a combination of cyclophosphamide and inhibition of chemo-resistant immune suppressor cells

Yu Saida, Satoshi Watanabe, Tomohiro Tanaka, Junko Baba, Koichiro Nozaki, Kosuke Ichikawa, Jun Koshio, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1550.
https://doi.org/10.1158/1538-7445.AM2012-1550
Published: 15 April 2012
View article titled, Abstract 1550: Successful treatment of advanced tumors with chemo-immunotherapy: a combination of cyclophosphamide and inhibition of chemo-resistant immune suppressor cells
Journal Articles

Abstract 2694: DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is a CD133+ tumor-specific protein and induces antitumor immunity

Jun Koshio, Hiroshi Kagamu, Kosuke Ichikawa, Junko Baba, Yu Saida, Satoshi Watanabe, Junta Tanaka, Hiroshi Tanaka, Hirohisa Yoshizawa, Ichiei Narita
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2694.
https://doi.org/10.1158/1538-7445.AM2011-2694
Published: 15 April 2011
View article titled, Abstract 2694: DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is a CD133+ tumor-specific protein and induces antitumor immunity
Journal Articles

Abstract 2685: Irradiation and reconstitution with in vitro-expanded polyclonal T cells from naïve mice augments antitumor response

Junko Baba, Satoshi Watanabe, Yu Saida, Kosuke Ichikawa, Jun Koshio, Junta Tanaka, Hiroshi Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2685.
https://doi.org/10.1158/1538-7445.AM2011-2685
Published: 15 April 2011
View article titled, Abstract 2685: Irradiation and reconstitution with in vitro-expanded polyclonal T cells from naïve mice augments antitumor response
Journal Articles

Abstract 1920: Chemo-resistant regulatory T cells inhibit the augmentation of antitumor immunity during homeostatic T cell proliferation

Junko Baba, Satoshi Watanabe, Kosuke Ichikawa, Jun Koshio, Takao Miyabayashi, Junta Tanaka, Hiroshi Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1920.
https://doi.org/10.1158/1538-7445.AM10-1920
Published: 15 April 2010
View article titled, Abstract 1920: Chemo-resistant regulatory T cells inhibit the augmentation of antitumor immunity during homeostatic T cell proliferation
Journal Articles

Abstract 5165: Cancer stem cells express specific immunogenic proteins that induce Th17-dominant immunity resulting in regression of parental tumor in vivo

Takao Miyabayashi, Hiroshi Kagamu, Jun Koshio, Kousuke Ichikawa, Junko Baba, Satoshi Watanabe, Junta Tanaka, Hiroshi Tanaka, Hirohisa Yoshizawa, Ko Nakata, Ichiei Narita
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5165.
https://doi.org/10.1158/1538-7445.AM10-5165
Published: 15 April 2010
View article titled, Abstract 5165: Cancer stem cells express specific immunogenic proteins that induce Th17-dominant immunity resulting in regression of parental tumor in vivo
Journal Articles

Abstract #370: Intratracheal administration of DC-based vaccine cells for tumor immunotherapy

Takeshi Ota, Hiroshi Tanaka, Takao Miyabayashi, Junko Baba, Satoshi Watanabe, Hideyuki Kuriyama, Junta Tanaka, Hiroshi Kagamu, Koh Nakata, Fumitake Gejyo, Hirohisa Yoshizawa
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 370.
Published: 01 May 2009
View article titled, Abstract #370: Intratracheal administration of DC-based vaccine cells for tumor immunotherapy
Journal Articles

Abstract #4132: Depletion of radio-resistatnt regulatory T cells enhances anti-tumor immunity during homeostatic proliferation

Junko Baba, Satoshi Watanabe, Takao Miyabayashi, Hiroshi Kagamu, Hiroshi Tanaka, Katsuya Deguchi, Chunrui Tan, Suyu Shu, Hirohisa Yoshizawa, Fumitake Gejyo
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4132.
Published: 01 May 2009
View article titled, Abstract #4132: Depletion of radio-resistatnt regulatory T cells enhances anti-tumor immunity during homeostatic proliferation
Journal Articles

Cyclic adoptive immunotherapy with cyclophosphamide for murine established skin tumor

Koki Matsuyama, Hiroshi Tanaka, Takeshi Ohta, Kenichi Koyama, Hideyuki Kuriyama, Junta Tanaka, Hiroshi Kagamu, Fumitake Gejyo, Hirohisa Yoshizawa
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 955.
Published: 01 May 2007
View article titled, Cyclic adoptive immunotherapy with cyclophosphamide for murine established skin tumor
Journal Articles

OVA peptide-responsive CD4+ effector T cells can induce antitumor immunity via epitope spreading mediated by dendritic cells.

Kenichi Koyama, Hiroshi Kagamu, Takeshi Ohta, Hideyuki Kuriyama, Hiroshi Tanaka, Junta Tanaka, Fumitake Gejyo, Ko Nakata, Hirohisa Yoshizawa
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2738.
Published: 01 May 2007
View article titled, OVA peptide-responsive CD4+ effector T cells can induce antitumor immunity via epitope spreading mediated by dendritic cells.
Journal Articles

The balance between effector and regulatory T cells in small cell lung cancer patients determine clinical stages

Satoru Miura, Hiroshi Kagamu, Toru Hiura, Koki Matsuyama, Kenichi Koyama, Hiroshi Tanaka, Junta Tanaka, Kou Nakata, Fumitake Gejyo, Hirohisa Yoshizawa
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 278–279.
Published: 15 April 2006
View article titled, The balance between effector and regulatory T cells in small cell lung cancer patients determine clinical stages
Journal Articles

CD62Lhigh CD4+CD25+ Regulatory T cells primed in tumor-draining lymph nodes abrogate antitumor efficacy of effector T cells via B7-2 / CTLA-4 T-T interaction

Tooru Hiura, Hiroshi Kagamu, Satoru Miura, Akira Ishida, Koki Matsuyama, Hiroshi Tanaka, Junta Tanaka, Hirohisa Yoshizawa, Fumitake Gejyo
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 624.
Published: 01 May 2005
View article titled, CD62Lhigh CD4+CD25+ Regulatory T cells primed in tumor-draining lymph nodes abrogate antitumor efficacy of effector T cells via B7-2 / CTLA-4 T-T interaction
Journal Articles

The duration of signaling through CD40 directs biological activity of dendritic cells to induce antitumor immunity.

Satoshi Watanabe, Hiroshi Kagamu, Akira Ishida, Tooru Hiura, Satoru Miura, Hiroshi Tanaka, Hirohisa Yoshizawa, Fumitake Gejyo
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 499.
Published: 01 April 2004
View article titled, The duration of signaling through CD40 directs biological activity of dendritic cells to induce antitumor immunity.
Journal Articles

Generation of anti-tumor effector T cells from naive spleen cells by stimulation with dendritic/tumor fusion cells

Hiroshi Tanaka, Akira Ishida, Toru Hiura, Satoru Miura, Satoshi Watanabe, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Fumitake Gejyo
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1085.
Published: 01 April 2004
View article titled, Generation of anti-tumor effector T cells from naive spleen cells by stimulation with dendritic/tumor fusion cells
Journal Articles

Clinical Observations on Adoptive Immunotherapy with Vaccine-primed T-Lymphocytes Secondarily Sensitized to Tumor in Vitro

Alfred E. Chang, Hirohisa Yoshizawa, Keisuke Sakai, Mark J. Cameron, Vernon K. Sondak, Suyu Shu
Journal: Cancer Research
Cancer Res (1993) 53 (5): 1043–1050.
Published: 01 March 1993
View article titled, Clinical Observations on Adoptive Immunotherapy with Vaccine-primed T-Lymphocytes Secondarily Sensitized to Tumor <em>in Vitro</em>
Open the PDF for Clinical Observations on Adoptive Immunotherapy with Vaccine-primed T-Lymphocytes Secondarily Sensitized to Tumor <em>in Vitro</em> in another window